Abstract
Before the use of melatonin can be recommended based on solid scientific evidence, further studies, conducted with adequate methods, are needed. A specific melatonin receptor agonist, ramelteon, has recently been approved as hypnotic. Although positive effects have been reported, extensive use in clinical practice would be necessary to confirm whether the statistically significant improvements are clinically meaningful, since the changes sometimes were relatively small, and the samples studied were large or very large.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 303-312 |
| Number of pages | 10 |
| Journal | Sleep Medicine Clinics |
| Volume | 2 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Neuropsychology and Physiological Psychology
- Clinical Psychology
- Clinical Neurology
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'Melatonin, Sleep, and Sleep Disorders'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver